Company Overview of ORCA Therapeutics B.V.
ORCA Therapeutics B.V., a biopharmaceutical company, designs and develops therapeutics for the treatment of cancer using Oncolytic Replication Competent Agents (ORCA). The ORCA agents/oncolytic viruses are derived from naturally occurring viruses and are engineered to selectively destroy cancer cells, while healthy cells are left unharmed. The Oncolytic viruses serve as delivery agents to express anti-cancer products at high levels in cancer cells and as anti-cancer vaccines that present cancer antigens to the immune system. ORCA Therapeutics B.V. offers ORCA-010, a therapeutic for the treatment of patients with colorectal cancer metastasized in the liver. The company’s oncolytic virotherapy...
De Boelelaan 1118
Amsterdam, 1081 HZ
Founded in 2005
Key Executives for ORCA Therapeutics B.V.
Compensation as of Fiscal Year 2014.
ORCA Therapeutics B.V. Key Developments
ORCA Therapeutics B.V. Presents at 2013 BIO Convention in China, Nov-11-2013
Oct 4 13
ORCA Therapeutics B.V. Presents at 2013 BIO Convention in China, Nov-11-2013 . Venue: China National Convention Center, No.7 Tianchen East Road, Chaoyang District, Beijing 100105, China.
ORCA Therapeutics BV Appoints Ronald Rodriguez to the Scientific Advisory Board
Sep 5 13
ORCA Therapeutics BV, announced that it has expanded its Scientific Advisory Board (SAB) with the appointment of Dr. Ronald Rodriguez. Dr. Rodriguez is currently Professor and Chairman of the Department of Urology at the University of Texas Health Science Center at San Antonio. He is an outstanding clinician and investigator focusing on prostate, bladder, and kidney cancer. Prof Ron Rodriguez will join existing members of ORCA’s SAB: Prof. Frank McCormick, Director of the Helen Diller Family Comprehensive Cancer Center & Cancer Research Institute of the University of California; Prof. Winald Gerritsen, medical oncologist at the Radboud University Nijmegen Medical Centre; and Dr. Ramon Alemany, laboratory director in the Catalan Institute of Oncology.
ORCA Therapeutics B.V. Presents at Sachs Associates Ltd.'s 12th Annual Biotech in Europe Investor Forum, Oct-02-2012 08:45 AM
Sep 27 12
ORCA Therapeutics B.V. Presents at Sachs Associates Ltd.'s 12th Annual Biotech in Europe Investor Forum, Oct-02-2012 08:45 AM. Venue: Hilton Zurich Airport Hotel, Zurich, Zurich, Switzerland.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries